SI1136081T1 - Sustained-release compositions for the parenteral administration of macrolides - Google Patents

Sustained-release compositions for the parenteral administration of macrolides

Info

Publication number
SI1136081T1
SI1136081T1 SI200130280T SI200130280T SI1136081T1 SI 1136081 T1 SI1136081 T1 SI 1136081T1 SI 200130280 T SI200130280 T SI 200130280T SI 200130280 T SI200130280 T SI 200130280T SI 1136081 T1 SI1136081 T1 SI 1136081T1
Authority
SI
Slovenia
Prior art keywords
macrolides
sustained
parenteral administration
release compositions
compositions
Prior art date
Application number
SI200130280T
Other languages
English (en)
Slovenian (sl)
Inventor
William David Steber
Sivaja Ranjan
Original Assignee
Wyeth Holdings Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings Corporation filed Critical Wyeth Holdings Corporation
Publication of SI1136081T1 publication Critical patent/SI1136081T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200130280T 2000-03-20 2001-03-16 Sustained-release compositions for the parenteral administration of macrolides SI1136081T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19069900P 2000-03-20 2000-03-20
EP01302438A EP1136081B1 (en) 2000-03-20 2001-03-16 Sustained-release compositions for the parenteral administration of macrolides

Publications (1)

Publication Number Publication Date
SI1136081T1 true SI1136081T1 (en) 2005-04-30

Family

ID=22702398

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130280T SI1136081T1 (en) 2000-03-20 2001-03-16 Sustained-release compositions for the parenteral administration of macrolides

Country Status (15)

Country Link
US (1) US6552002B2 (xx)
EP (1) EP1136081B1 (xx)
JP (1) JP4817515B2 (xx)
AR (1) AR027681A1 (xx)
AT (1) ATE286406T1 (xx)
AU (1) AU781682B2 (xx)
BR (1) BR0101090A (xx)
CA (1) CA2341281C (xx)
DE (1) DE60108189T2 (xx)
DK (1) DK1136081T3 (xx)
ES (1) ES2233566T3 (xx)
MX (1) MXPA01002861A (xx)
NZ (1) NZ510538A (xx)
PT (1) PT1136081E (xx)
SI (1) SI1136081T1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531460A (en) * 2001-10-19 2005-05-27 Idexx Lab Inc Controlled release - over at least 4-15 days - of injectable compositions comprising a lipophilic counterion such a saturated or unsaturated C10-C18 fatty acid
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
US7906128B2 (en) * 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7582612B2 (en) * 2004-03-12 2009-09-01 Hartz Mountain Corporation Multi-action anthelmintic formulations
GB0425919D0 (en) * 2004-11-25 2004-12-29 Prosidion Ltd Indole-2-carboxylic acid amides
EP2351713B1 (en) 2008-09-09 2013-08-14 Asahi Glass Company, Limited Air-cool intensifying apparatus for glass plate, and air-cool intensifying method
UY33282A (es) * 2010-03-25 2011-09-30 Novartis Ag Composiciones endoparasiticidas
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR20140136005A (ko) 2012-03-13 2014-11-27 바이엘 뉴질랜드 리미티드 지속성 조성물
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
AU2014223993B2 (en) 2013-02-28 2016-09-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
GB2552952B (en) * 2016-08-12 2020-03-04 Norbrook Lab Ltd Moxidectin topical liquid formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
EP3975994A4 (en) * 2019-05-24 2023-06-14 Piedmont Animal Health Inc. LONG-ACTING INJECTABLE FORMULATIONS AND THEIR USE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
JPS57171919A (en) * 1981-04-17 1982-10-22 Nippon Kayaku Co Ltd Orally administering composition for veterinary purposes
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
CA2259469A1 (en) * 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration

Also Published As

Publication number Publication date
US6552002B2 (en) 2003-04-22
ATE286406T1 (de) 2005-01-15
NZ510538A (en) 2002-06-28
DE60108189T2 (de) 2005-06-02
ES2233566T3 (es) 2005-06-16
JP4817515B2 (ja) 2011-11-16
AR027681A1 (es) 2003-04-09
DE60108189D1 (de) 2005-02-10
CA2341281A1 (en) 2001-09-20
PT1136081E (pt) 2005-03-31
MXPA01002861A (es) 2002-06-04
CA2341281C (en) 2010-11-02
AU781682B2 (en) 2005-06-09
JP2001261558A (ja) 2001-09-26
EP1136081B1 (en) 2005-01-05
DK1136081T3 (da) 2005-02-21
AU2641501A (en) 2001-09-27
US20020004486A1 (en) 2002-01-10
BR0101090A (pt) 2001-11-06
EP1136081A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
SI1136081T1 (en) Sustained-release compositions for the parenteral administration of macrolides
GB2358582B (en) Pharmaceutical compositions
HUP0204114A3 (en) Pharmaceutical parenteral composition containing biphosphonate
HUP0203707A3 (en) Oligosaccharide mixture
HUP0300582A3 (en) Pharmaceutical compositions
GB0107758D0 (en) Anti-cancer compounds
AU6219601A (en) Pharmaceutical compositions
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HUP0400553A3 (en) Pharmaceutical compositions
HK1055906A1 (en) Pharmaceutical dronedarone composition for parenteral administration
AU2002217229A1 (en) Pharmaceutical dronedarone composition for parenteral administration
AU1390002A (en) Pharmaceutical compositions
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0125901D0 (en) Compositions stabilized dioxopiperazinyl derivatives
IL160973A0 (en) Macrolides containing pharmaceutical compositions
AU7827301C9 (en) Stable compositions for parenteral administration
AU7827301C1 (en) Stable compositions for parenteral administration
IL128359A0 (en) Methods for the preparation of erythromycin derivatives
GB0001337D0 (en) Pharmaceutical compositions
HU0700204D0 (en) Pharmaceutical compositions
GB0031288D0 (en) Pharmaceutical compositions